“Infectious Diseases and Clinical Microbiology Specialist”
After graduating from Azerbaijan Medical University in 2015, I continued my medical career in Turkey. I completed my internal medicine rotations at Istanbul Medical Faculty and Dr. Sadi Konuk Training and Research Hospital. Between 2018-2024, I completed my specialization in Infectious Diseases and Clinical Microbiology at Istanbul Medical Faculty. I currently serve my patients as an infectious diseases specialist at Medicana International Beylikdüzü.
Education
2009 - 2015
Medical School
Azerbaijan Medical University
2018 - 2024
Infectious Diseases and Clinical Microbiology Specialization
Istanbul Medical Faculty
Professional Experience
2016
Internal Medicine
Istanbul Medical Faculty
2017 - 2018
Internal Medicine
Dr. Sadi Konuk Training and Research Hospital
2024 - Present
Infectious Diseases Specialist
Medicana International Beylikdüzü
Scientific Studies
24. Ulusal Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi
- Disseminated cryptococcosis with meningeal, pulmonary, and cutaneous involvement in a liver transplant recipient: a case report
- Resistant Klebsiella pneumoniae infections: Comparison of clinical and laboratory features of patients receiving standard or high-dose tigecycline therapy
HIV/AIDS 2023 Kongresi
- Evaluation of treatment response in individuals living with HIV diagnosed with ocular syphilis
23. Ulusal Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi
- Comparison of herpes zoster patients with and without immunosuppression
- Complicated cutaneous leishmaniasis and possible talaromycosis (penicilliosis) coexistence in an individual living with HIV
22. Ulusal Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi
- A case of infective endocarditis caused by Lactobacillus paracasei
21. Ulusal Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi
- A case of pyoderma gangrenosum mimicking necrotizing fasciitis
- A Phase 2/3, double-blind, 2-arm, interventional efficacy and safety study comparing orally administered PF-07321332/Ritonavir with placebo in symptomatic adult volunteers with COVID-19 at low risk of progression to severe illness who are managed on an outpatient basis